Use of 7-fluoro-4-nitrobenzo-2-oxo-1,3-diazole (NBD-F) for the determination of ramipril in tablets and spiked human plasma

被引:14
作者
Al-Majed, AA [1 ]
Al-Zehouri, J [1 ]
机构
[1] King Saud Univ, Coll Pharm, Dept Pharmaceut Chem, Riyadh 11451, Saudi Arabia
来源
FARMACO | 2001年 / 56卷 / 04期
关键词
ramipril; plasma; tablets; fluorimetry; colorimetry; ACE; NBD-F;
D O I
10.1016/S0014-827X(01)01070-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ramipril, as a secondary amine compound, reacts with 7-fluoro-4-nitrobenzo-2-oxo-1,3-diazole (NBD-F) producing the corresponding fluorescent NBD-ramipril. According to this fact, spectrophotometric and fluorimetric methods for the determination of ramipril were developed. The effect of these parameters on the reaction product were carefully studied to optimize reaction conditions. The relationship between the absorbance at 465 nm and the concentration was found to be linear over the range 1-10 mug/ml. Moreover, the fluorescence intensity was also found to be directly proportional at the concentration over the range of 20-100 ng/ml at 530 nm after excitation at 465 nm. The proposed procedure was successfully applied to the determination of ramipril in both tablet dosage form and in plasma. Spectrophotometric determination of ramipril tablets yielded a percentage recovery of 98.66 +/- 0.38, while the percentage recovery of spectrofluorimetric determination of ramipril in spiked human plasma was 99.08 +/- 1.11%. The results obtained are in good agreement with those obtained by the reference method. No interference could be observed from the co-administered drug (hydrochlorothiazines). (C) 2001 Elsevier Science S.A. All rights reserved.
引用
收藏
页码:291 / 296
页数:6
相关论文
共 20 条
[1]   Spectrophotometric and atomic absorption spectrometric determination of ramipril and perindopril through ternary complex formation with eosin and Cu(II) [J].
Abdellatef, HE ;
Ayad, MM ;
Taha, EA .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1999, 18 (06) :1021-1027
[2]  
AboulEnein HY, 1997, ANAL LETT, V30, P1999
[3]   HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC IDENTIFICATION OF RAMIPRIL, AND ITS PRECURSOR ENANTIOMERS USING A CHIRALPAK OT(+)- COLUMN [J].
ABOULENEIN, HY ;
BAKR, SA .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1992, 18 (09) :1013-1022
[4]   DETERMINATION OF RAMIPRIL AND ITS PRECURSORS BY REVERSE PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
ABOULENEIN, HY ;
THIFFAULT, C .
ANALYTICAL LETTERS, 1991, 24 (12) :2217-2224
[5]   The voltammetric study and determination of ramipril in dosage forms and biological fluids [J].
Al-Majed, AA ;
Belal, F ;
Abadi, A ;
Al-Obaid, AM .
FARMACO, 2000, 55 (03) :233-238
[6]   Analysis of ACE inhibitors in pharmaceutical dosage forms by derivative UV spectroscopy and liquid chromatography (HPLC) [J].
Bonazzi, D ;
Gotti, R ;
Andrisano, V ;
Cavrini, V .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1997, 16 (03) :431-438
[7]  
Christian G. D., 1986, INSTRUMENTAL ANAL
[8]  
DONAUBAUER HH, 1998, ARZNEIM FORSCH DRUG, V38, P14
[9]  
ECKERT HG, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1251
[10]   AVAILABILITY OF FLUOROGENIC REAGENTS HAVING A BENZOFURAZAN STRUCTURE IN THE BIOSCIENCES [J].
IMAI, K ;
UZU, S ;
KANDA, S ;
BAEYENS, WRG .
ANALYTICA CHIMICA ACTA, 1994, 290 (1-2) :3-20